The company, Indivior, had allegedly attempted to “destroy competition” by preventing the introduction of generic versions of its drug Suboxone.
Wisconsin leads $102.5 million antitrust settlement with Suboxone manufacturer Indivior
The company, Indivior, had allegedly attempted to “destroy competition” by preventing the introduction of generic versions of its drug Suboxone.